M Aviram|J G Brook - JoVE Visualize

Showing results (241-250 of 255) with videos related to

Pageof 26

Sort By:

Clinical Cardiology|June 1, 1989

Familial homozygous hypercholesterolemia: clinical and cardiovascular features in 18 patientsG J Brook, S Keidar, M Boulos, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|October 9, 1998

Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and RM Aviram, S Billecke, R Sorenson, et al.

Genomics|November 4, 1998

The molecular basis of disease variability among cystic fibrosis patients carrying the 3849+10 kb C-->T mutationO Chiba-Falek, E Kerem, T Shoshani, et al.

Molecular and Cellular Biology|March 19, 1999

SAG, a novel zinc RING finger protein that protects cells from apoptosis induced by redox agentsH Duan, Y Wang, M Aviram, et al.

Scientific Reports|February 9, 2016

Novel Osteogenic Ti-6Al-4V Device For Restoration Of Dental Function In Patients With Large Bone Deficiencies: Design, Development And ImplementationD J Cohen, A Cheng, A Kahn, et al.

Pediatric Pulmonology|November 9, 2004

Trampoline use as physiotherapy for cystic fibrosis patientsA Barak, I D Wexler, O Efrati, et al.

Clinical and Experimental Medicine|January 28, 2005

Systemic inflammatory mediators and cystic fibrosis genotypeA Augarten, G Paret, I Avneri, et al.

Pediatrics|January 26, 1999

Clinical and genetic risk factors for cystic fibrosis-related liver diseaseM Wilschanski, J Rivlin, S Cohen, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|January 9, 2001

Simvastatin preserves coronary endothelial function in hypercholesterolemia in the absence of lipid loweringS H Wilson, R D Simari, P J Best, et al.

Drugs Under Experimental and Clinical Research|September 13, 2002

Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humansM Aviram, L Dornfeld, M Kaplan, et al.

Pageof 26

Showing results (241-250 of 255) with videos related to

Sort By:

Pageof 26

Clinical Cardiology|June 1, 1989

Familial homozygous hypercholesterolemia: clinical and cardiovascular features in 18 patientsG J Brook, S Keidar, M Boulos, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|October 9, 1998

Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and RM Aviram, S Billecke, R Sorenson, et al.

Genomics|November 4, 1998

The molecular basis of disease variability among cystic fibrosis patients carrying the 3849+10 kb C-->T mutationO Chiba-Falek, E Kerem, T Shoshani, et al.

Molecular and Cellular Biology|March 19, 1999

SAG, a novel zinc RING finger protein that protects cells from apoptosis induced by redox agentsH Duan, Y Wang, M Aviram, et al.

Scientific Reports|February 9, 2016

Novel Osteogenic Ti-6Al-4V Device For Restoration Of Dental Function In Patients With Large Bone Deficiencies: Design, Development And ImplementationD J Cohen, A Cheng, A Kahn, et al.

Pediatric Pulmonology|November 9, 2004

Trampoline use as physiotherapy for cystic fibrosis patientsA Barak, I D Wexler, O Efrati, et al.

Clinical and Experimental Medicine|January 28, 2005

Systemic inflammatory mediators and cystic fibrosis genotypeA Augarten, G Paret, I Avneri, et al.

Pediatrics|January 26, 1999

Clinical and genetic risk factors for cystic fibrosis-related liver diseaseM Wilschanski, J Rivlin, S Cohen, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|January 9, 2001

Simvastatin preserves coronary endothelial function in hypercholesterolemia in the absence of lipid loweringS H Wilson, R D Simari, P J Best, et al.

Drugs Under Experimental and Clinical Research|September 13, 2002

Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humansM Aviram, L Dornfeld, M Kaplan, et al.

Pageof 26